Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-28 @ 3:21 PM
Study NCT ID:
NCT01032850
Status:
TERMINATED
Last Update Posted:
2021-06-02
First Post:
2009-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-14
First Submit QC Date:
None
Study First Post Date:
2009-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-06
Results First Submit QC Date:
None
Results First Post Date:
2015-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-11
Last Update Post Date:
2021-06-02
Last Update Post Date Type:
ACTUAL